Dublin, Dec. 20, 2021 (GLOBE NEWSWIRE) -- The "Global Soft Tissue Repair Market (2021-2026) by Product, Application And Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.
The Global Soft Tissue Repair Market is estimated to be USD 10.4 Bn in 2021 and is expected to reach USD 16.9 Bn by 2026, growing at a CAGR of 10.2%.
The current treatment options rely heavily on surgical procedures, which have a low success rate. Therefore, it is imperative to find superior, technologically advanced alternatives such as minimally invasive procedures and rapid healing products.
Factors such as lack of substitutes, increase in incidences of soft tissue injuries, increasing participation in sports activities, increasing ageing population and obesity rate and geographic expansion by leading players in developing countries are driving the market. Whereas the high cost of surgical procedures, and limited or lack of reimbursement are restraining factors for the market.
Growing investment potential in emerging markets provides an opportunity for the market but lack of awareness and limited reimbursement policies acts as a challenge to it.
By Product, the market is classified into Tissue Patch/Mesh, Fixation Products and Laparoscopic Instruments segments. Amongst all segments, the Laparoscopic Instruments segment is expected to grow at the highest CAGR.
By Application, the market is classified into Hernia Repair, Dural Repair, Vaginal Sling Procedures, Skin Repair, Orthopaedic, Dental and Breast Reconstruction Repair segments. Amongst all, the Hernia Repair segment is expected to contribute the highest growth.
By Geography, North America is projected to lead the market.
Orthocell's strong cash balance allows the company to progress key regulatory approvals and commercialisation strategy - 4th May 2021
CollPlant announces the development and global commercialization agreement with Allergan Aesthetics, an AbbVie company, for rhCollagen in Dermal and Soft Tissue Filler Products - 8th February 2021
Lack of Substitutes
Increase in Incidences of Soft Tissue Injuries
Increasing Participation in Sports Activities
Increasing Aging Population and Obesity Rate
Geographic Expansion by Leading Players in Developing Countries
High Cost of Surgical Procedures
Limited or Lack of Reimbursement
Growing Investment Potential in Emerging Markets
Lack of awareness and limited reimbursement policies
Some of the companies covered in this report are
Smith & Nephew PLC
Becton, Dickinson and Company (C.R. Bard)
Allergan Plc. (LifeCell Corporation)
Johnson & Johnson
Lifenet Health, Inc.
Zimmer Biomet Holdings, Inc.
Integra Lifesciences Corporation
American Medical Systems Inc.
Acera Surgical Inc
Baxter International Inc.
Boston Scientific Corporation
GE Healthcare Inc.
Institut Straumann AG
For more information about this report visit https://www.researchandmarkets.com/r/h062xt
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900